IP Library Granted Patent US 7,268,241
Granted Patent B2
US 7,268,241 · App. 10/416,234 · Granted Sep 11, 2007

Method for the production of 4-(17$g(a)-methyl substituted 3-oxoestra-4 9-dien-11$g(b)-yl)benzaldehyd-(1e or 1z)-oximes

Assignee: Schering AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,268,241
App. No.
10/416,234
Granted
Sep 11, 2007
Kind
B2
Abstract

The invention relates to a process for the production of 4-(17α-methyl-substituted 3-oxoestra-4,9-dien-11β-yl)benzaldehyde-(1E or 1Z)-oximes of general formula (I), in which R 1 is a hydrogen atom, a C 1-6 -alkyl radical or a C n F 2n+1 radical, whereby n is 1, 2 or 3, R 2 is a C 1-4 -alkyl radical, X is an OH group in E- or Z-position, and Y is an OC 1-6 -alkyl group, an SC 1-6 -alkyl group or an OCH 2 C n F 2+1 group, whereby n is 1, 2 or 3, which provides the target compounds of formula (I) with a high yield and good selectivity

Claims (85)

1. A process for preparing a 4-(17α-methyl-substituted 3-oxoestra-4,9-dien-11β-yl) benzaldehyde-(1E or 1Z)-oxime of formula (I)

in which

R 1 is a hydrogen atom, a C 1-6 -alkyl radical or a C n F 2n+1 radical,

R 2 is a C 1-4 -alkyl radical or a trifluoromethyl group,

X is an OH group in E- or Z-position,

Y is an OC 1-6 -alkyl group, an SC 1-6 -alkyl group or an OCH 2 C n F 2n+1 group, and

n is 1, 2 or 3,

comprising

converting a 3,3-dimethoxy-estra-5(10),9(11)-en-17-one compound of formula (IX)

in which

R 2 is a C 1-4 -alkyl radical or a trifluoromethyl group,

with an active methylene reagent in an inert solvent into a spiroepoxide compound of formula (X)

in which

R 2 is a C 1-4 -alkyl radical or a trifluoromethyl group,

cleaving the 17-spiroepoxy group of the compound of formula (X) with an alkali or alkaline-earth alcoholate, alkali or alkaline-earth thiol alcoholate or a trifluoroalkyl alcohol and potassium-tert-butanolate in an inert solvent, and forming a 17α-CH 2 Y compound of formula (XI)

in which

R 1 is a hydrogen atom,

R 2 is a C 1-4 -alkyl radical or a trifluoromethyl group, and

Y is an OC 1-6 -alkyl group, an SC 1-6 -alkyl group or an OCH 2 C n F 2n+1 group,

optionally reacting the 17β-hydroxyl group of the compound of formula (XI) with an alkyl halide or fluoroalkyl iodide in the presence of a strong base in an inert solvent to form a 17β-ether of formula (XI″),

in which

R 1 is a C 1-6 -alkyl radical or a C n F 2n+1 radical,

R 2 is a C 1-4 -alkyl radical or a trifluoromethyl group, and

Y is an OC 1-6 -alkyl group, an SC 1-6 -alkyl group or an OCH 2 C n F 2n+1 group,

epoxidizing the compound of formula (XI) or (XI″) on the 5(10)-double bond thereof, producing a mixture of 5α, 10α-epoxy- and 5β, 10β-epoxy-17α-methyl-substituted estr-9(11)-ene-3,3-dimethyl ketals of formula (XII)

in which

R 1 is a hydrogen atom, a C 1-6 -alkyl radical or a C n F 2n+1 radical,

R 2 is a C 1-4 -alkyl radical or a trifluoromethyl group, and

Y is an OC 1-6 -alkyl group, an SC 1-6 -alkyl group or an OCH 2 C n F 2n+1 group,

reacting the compound of formula (XII) with a 4-bromobenzaldehyde ketal, magnesium and Cu(I)Cl at a temperature of between −35°C. and room temperature form a 3,3-dimethoxy-5α-hydroxy-17α-methyl-substituted 11α,β-benzaldehydedimethyl ketal of formula (XIII)

in which

R 1 is a hydrogen atom, a C 1-6 -alkyl radical or a C n F 2n+1 radical,

R 2 is a C 1-4 -alkyl radical or a trifluoromethyl group, and

Y is an OC 1-6 -alkyl group, an SC 1-6 -alkyl group or an OCH 2 C n F 2n+1 group,

subjecting the compound of formula (XIII) to acid hydrolysis to cleave any protective groups, to form a mixture of 11α,β-benzaldehyde compounds of formula (XIV)

in which

R 1 is a hydrogen atom, a C 1-6 -alkyl radical or a C n F 2n+1 radical,

R 2 is a C 1-4 -alkyl radical or a trifluoromethyl group, and

Y is an OC 1-6 -alkyl group, an SC 1-6 -alkyl group or an OCH 2 C n F 2n+1 group,

isolating by crystallizing a pure 11β-benzaldehyde compound, and

converting the aldehyde function of said 11β-benzaldehyde compound by a hydroxylammonium salt in the presence of a base at room temperature into a mixture of E/Z-benzaldoximes of formula (I).

2. A process according to claim 1 , further comprising separating the mixture of the E/Z-benzaldoximes of formula (I) into E or Z-benzaldoximes by recrystallization and/or by chromatography.

3. A process according to claim 1 , wherein R 1 is a C 1-3 -alkyl radical.

4. A process according to claim 1 , wherein R 2 is a C 1-3 -alkyl radical.

5. A process according to claim 1 , wherein Y is an OC 1-3 -alkyl radical or an SC 1-3 -alkyl radical.

6. A process according to claim 1 , wherein

4-[17β-Hydroxy-17α-(methoxymethyl)-3-oxoestra-4,9-dien-11β-yl]benzaldehyde-1E-oxime,

4-[17β-Hydroxy-17α-(methoxymethyl)-3-oxoestra-4,9-dien-11β-yl]benzaldehyde-1Z-oxime,

4-[17β-Methoxy-17α-(methoxymethyl)-3-oxoestra-4,9-dien-11β-yl]benzaldehyde-1E-oxime,

4-[17β-Methoxy-17α-(methoxymethyl)-3-oxoestra-4,9-dien-11β-yl]benz-aldehyde-1Z-oxime,

4-[17β-Ethoxy-(17α-(methoxymethyl)-3-oxoestra-4,9-dien-11β-yl]benzaldehyde-1E-oxime,

4-[17β-Hydroxy-17α-(ethoxymethyl)-3-oxoestra-4,9-dien-11β-yl]benzaldehyde-1E-oxime,

4-[17β-Methoxy-17α-(ethoxymethyl)-3-oxoestra-4,9-dien-11β-yl]benzaldehyde-1E-oxime,

4-[17β-Hydroxy-17α-(isopropyloxymethyl)-3-oxoestra-4,9-dien-11β-yl]benzaldehyde-1E-oxime,

4-[17β-Methoxy-17α-(isopropyloxymethyl)-3-oxoestra-4,9-dien-11β-yl]benzaldehyde-1E-oxime,

4-[17β-Hydroxy-17α-(ethylthiomethyl)-3-oxoestra-4,9-dien-11β-yl]benzaldehyde-1E-oxime, or

4-{17β-Hydroxy-17α-(1,1,1-trifluoroethoxymethyl)-3-oxoestra-4,9-dien-11β-yl]benzaldehyde-1E-oxime

is prepared.

7. A process according to claim 1 , wherein R 1 is a methyl group or a trifluoromethyl group.

8. A process according to claim 1 , wherein R 2 is a methyl group or a trifluoromethyl group.

9. A process according to claim 1 , wherein Y is a methoxy, ethoxy, isopropyloxy, methylthio, ethylthio, or trifluoroethoxy group.

10. A process according to claim 1 , wherein R 2 is a methyl group.

11. A process according to claim 1 , wherein R 2 is a C 1-4 -alkyl radical.

12. A process according to claim 1 , wherein Y is a methoxy, ethoxy, isopropyloxy, methylthio, or ethylthio group.

13. A process according to claim 1 , wherein the isolated 11β-benzaldehyde compound is a compound of the following formula

wherein R 1 is a hydrogen atom or a C 1-6 -alkyl radical.

14. A compound of formula (I),

wherein

R 1 is a C n F 2n+1 radical,

n is 1, 2 or 3,

R 2 is a C 1-4 -alkyl radical or a trifluoromethyl group,

X is an OH group in E- or Z-position, and

Y is an OC 1-6 alkyl group, an SC 1-6 -alkyl group or an OCH 2 C n F 2n+1 group.

15. A compound of formula (I),

wherein

Y is an OCH 2 C n F 2n+1 group,

n is 1, 2 or 3,

R 1 is a hydrogen atom, a C 1-6 -alkyl radical or a C n F 2n+1 radical,

R 2 is a C 1-4 -alkyl radical or a trifluoromethyl group, and

X is an OH group in E- or Z-position.

16. A compound according to claim 14 , wherein R 2 is a C 1-4 -alkyl radical.

17. A compound according to claim 15 , wherein R 2 is a C 1-4 -alkyl radical.

18. A compound according to claim 15 , wherein R 1 is a C 1-6 -alkyl radical or a C n F 2n+1 radical.

19. A compound according to claim 14 , wherein n is 1.

20. A compound according to claim 15 , wherein n is 1.

Assignments (4)
CHANGE OF NAME Recorded May 17, 2013
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 030434/0232 →
CHANGE OF NAME Recorded May 17, 2013
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 030442/0400 →
CHANGE OF NAME Recorded May 17, 2013
From: SCHERING AG
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 030452/0021 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2003
From: SCHUBERT, GERD; RING, SEVEN; ERHART, BERND; MUELLER, GERD
To: SCHERING AG
Reel/Frame 014690/0492 →
Priority Claims (1)
DE 100 56 675 · Nov 10, 2000 · national
Continuity (1)
Related Publication 20040063172A1 · Apr 1, 2004